Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1067 | 985 | 1220 | 1079 | 1348 | - |
Fund Return | 6.7% | -1.51% | 21.98% | 2.55% | 6.16% | - |
Place in category | 466 | 455 | 391 | 179 | 279 | - |
% in Category | 66 | 67 | 62 | 31 | 45 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Great-West S&P 500 Index Init | 5.14B | 20.42 | 8.50 | 12.40 | ||
Great-West International Index Init | 1.68B | 6.38 | 2.14 | 4.72 | ||
Great-West Moderate Profile II Init | 1.61B | 8.29 | 2.56 | 5.99 | ||
Great-West S&P 500 Index Instituti | 1.35B | 20.77 | 8.88 | - | ||
Great-West Conservative Profile II | 1.13B | 5.42 | 1.16 | 3.76 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Vanguard Total Intl Stock Index Inv | 204.36B | 8.15 | 1.40 | 4.88 | ||
Vanguard Total Intl Stock Index Adm | 75.61B | 8.18 | 1.45 | 4.94 | ||
Fidelity International Index Inst | 52.9B | 6.96 | 2.81 | 5.35 | ||
Fidelity Series Global ex US Index | 48.18B | 8.52 | 1.64 | 4.77 | ||
Strategic Advisers International I | 42.32B | 8.45 | 1.91 | 6.07 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 2.76 | 743.4 | -2.03% | |
ASML Holding | NL0010273215 | 2.41 | 627.70 | -1.92% | |
United States Treasury Bills 0% | - | 2.09 | - | - | |
Nestle | CH0038863350 | 1.61 | 76.36 | +0.69% | |
AstraZeneca | GB0009895292 | 1.43 | 10,532.0 | +0.38% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review